TheraDiag SA announced the appointment of Professor Gerard Tobelem as the new Chairman of the Board of Directors and the arrival of Pierre Morgon and Jean-Paul Prieels as new Board members. The former Head of the Hematology Department at Lariboisiere Hospital (Paris) Professor Gerard Tobelem has been appointed as the President of Theradiag's Board of Directors. He is an Officer of the French Legion of Honor. Gerard Tobelem served as Chief Executive of the French national blood transfusion service from April 2009 to April 2012. Jean-Paul Prieels pursued career in GlaxoSmithKline Biologicals' R&D Division from 1987 until 2011, leaving the company as Senior Vice President, Research & Development. Pharmaceutical industry expert, Pierre Morgon also joins the Board of Directors. Pierre Morgon currently serves as Vice President Franchise & Global Marketing Strategy of Sanofi Pasteur. Philippe Pouletty MD served as Theradiag's CEO and then Chairman of the Board since 2009. He was notably responsible for restructuring the company. Philippe Pouletty remains on the Board and will continue to bring his major contribution to the company's strategy.